CompaniesEnteric Medical

Enteric Medical

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

303

By Phase

NA: 3PHASE3: 1

By Status

RECRUITING: 4TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT06661668
NCT05980455
NCT06560307
NCT06464926
Hover over trial bars to see details

Recent Trials

NCT06464926Lead Sponsor
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
NARecruiting
148 participants
Started: Jun 23, 2025 · Completed: Jun 30, 2030
NCT06560307Lead Sponsor
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
NARecruiting
50 participants
Started: Jul 25, 2024 · Completed: Dec 31, 2026
NCT05980455Lead Sponsor
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
NARecruiting
50 participants
Started: Jul 10, 2023 · Completed: Dec 31, 2025
NCT06661668Collaborator
Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis
N/ARecruiting
50 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2026
NCT03335059Lead Sponsor
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.
PHASE3Terminated
5 participants
Started: Apr 4, 2019 · Completed: Feb 26, 2020